Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vistagen Therapeutics (VTGN) Preferred Dividend Payments (2016 - 2021)

Vistagen Therapeutics' Preferred Dividend Payments history spans 7 years, with the latest figure at $208000.0 for Q4 2021.

  • For Q4 2021, Preferred Dividend Payments fell 41.18% year-over-year to $208000.0; the TTM value through Dec 2021 reached $1.3 million, down 4.18%, while the annual FY2022 figure was $945000.0, 31.8% down from the prior year.
  • Preferred Dividend Payments for Q4 2021 was $208000.0 at Vistagen Therapeutics, down from $375200.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $375200.0 in Q3 2021 and bottomed at $208000.0 in Q4 2021.
  • The 5-year median for Preferred Dividend Payments is $302500.0 (2019), against an average of $304100.0.
  • The largest annual shift saw Preferred Dividend Payments skyrocketed 122.59% in 2017 before it plummeted 41.18% in 2021.
  • A 5-year view of Preferred Dividend Payments shows it stood at $263000.0 in 2017, then increased by 10.61% to $290900.0 in 2018, then increased by 7.87% to $313800.0 in 2019, then grew by 12.68% to $353600.0 in 2020, then tumbled by 41.18% to $208000.0 in 2021.
  • Per Business Quant, the three most recent readings for VTGN's Preferred Dividend Payments are $208000.0 (Q4 2021), $375200.0 (Q3 2021), and $361800.0 (Q2 2021).